Track market-moving stories before they get noisy

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Werner Enterprises (WERN - Free Report) Werner Enterprises, Inc. is a transportation and logistics company founded in 1956. Headquartered in Omaha, NE, the company is primarily focused on transporting the truckload shipments such as retail store merchandise, consumer products, grocery products and manufactured products. The company operates mainly under two segments — Truckload Transporation Services (TTS) and Werner Logistics.

WERN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Transportation stock. WERN has a Momentum Style Score of B, and shares are up 2.2% over the past four weeks.

For fiscal 2026, four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.10 to $0.94 per share. WERN boasts an average earnings surprise of +30.6%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, WERN should be on investors' short list.

IRVING, Texas--(BUSINESS WIRE)--Nexstar Media Group, Inc. (NASDAQ: NXST) (“Nexstar” or “the Company”) announced that at its 2026 Annual Shareholders' Meeting shareholders voted to: Elect all nominees to Nexstar's Board of Directors; Affirm the executive compensation of the Company's Named Executive Officers; Ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026; and, Approve the 2026 Long-Term Omni.

I am upgrading Park Hotels & Resorts to a buy, driven by strong market momentum, property upgrades, and resilient top-line growth. PK demonstrates competitive positioning with a focus on upper-upscale renovations, notably achieving +27% group revenue growth at the Royal Palm South Beach. Despite volatile FFO and high leverage, PK offers a safe, elevated dividend yield (~6.8%) with solid coverage, though dividend growth is muted.

© SWKStock / Shutterstock.com

Income hunters know Invesco KBW Premium Yield Equity REIT ETF (NASDAQ:KBWY) as one of the highest-yielding equity REIT funds on the market, with a 30-day SEC yield of 8.26% and a 12-month distribution rate of 8.6%. KBWY achieves that yield by weighting small and mid-cap REITs by dividend payout rather than market cap, loading the portfolio with rent rolls Wall Street tends to overlook. The question for KBWY holders is whether those rent checks can keep funding monthly distributions of roughly $0.12 per share when the 10-year Treasury sits near 4.5% and refinancing costs remain elevated.

How the rent roll feeds the distribution KBWY tracks the KBW Nasdaq Premium Yield Equity REIT Index, a yield-weighted basket of roughly 30 small and mid-cap REITs. Because REITs must distribute at least 90% of taxable income to maintain tax pass-through status, KBWY’s monthly payout is essentially pooled rent, lease, and mortgage income from underlying landlords. The fund charges a 0.35% expense ratio and manages roughly $291 million in assets, modest enough that distribution cuts at the top can move the needle.

The holdings doing the heavy lifting The top 10 names account for about 43% of assets, so their cash flows matter disproportionately. Three concentrate the safety question:

Innovative Industrial Properties (NYSE:IIPR), the cannabis-focused triple-net REIT, sits at about 6.4% of the fund. Tenant concentration in a still-federally-illegal industry has produced rent defaults that forced AFFO guidance lower in recent quarters. The dividend has been held flat, but coverage has thinned, and a single major tenant loss would hit KBWY’s distribution within a quarter. Community Healthcare Trust (NYSE:CHCT) is about 4.6% of assets. Medical-office leases are sticky, but CHCT’s payout ratio has run above 100% of FFO, meaning the dividend is funded partly by debt and ATM equity issuance rather than operating cash flow. That is the textbook setup for an eventual trim. SL Green Realty (NYSE:SLG | SLG Price Prediction) at about 4.2% represents the Manhattan office trade. Leasing momentum has improved, and management reset the dividend lower in 2023, so the current payout looks defensible. Valuation is the bigger concern than coverage here. Hotel exposure through Park Hotels & Resorts (NYSE:PK) adds operating leverage to RevPAR trends, fine in expansion but the first lever cut in a slowdown.

What the distribution history actually says KBWY’s monthly payout has held in a tight $0.1225 to $0.1253 band across every month of 2025 and into 2026. That stability is genuine, but it follows a long reset: distributions peaked near $0.21 in 2020 before stepping down as small-cap REITs cut payouts through the rate-hiking cycle. The bleeding has stopped. The cautionary note is that KBWY has historically tracked its underlyings down quickly when they cut.

Total return puts the yield in context Price-only performance has finally turned. KBWY is up 18% year-to-date and 23% over the past year, with shares around $17. Over five years the price is up just 14%, a reminder that the distribution has carried the total-return story and NAV is sensitive to long rates. With the 10-year near the top of its 12-month range and the 2s/10s spread compressing to 0.46%, refinancing risk for highly levered small-cap REITs remains the biggest swing factor.

The verdict on KBWY’s income KBWY’s distribution looks safe in the near term and fragile over a full cycle. Monthly payouts have been stable for over a year, top holdings are mostly covering their dividends, and the fund’s yield-weighted methodology automatically rotates out of names that cut. Holders should expect the headline yield to drift lower if rates stay elevated and one or two top holdings reset payouts, but a sudden distribution collapse would require a broader small-cap REIT credit event. Investors who want REIT-adjacent income with lower volatility and meaningful dividend growth, rather than the highest current yield, typically look outside the small-cap REIT universe entirely.

New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Corcept Therapeutics Incorporated failed to disclose adverse facts concerning potential FDA approval of one of the Company's lead new product candidates, relacorilant, a medication being developed for multiple indications, including the treatment of hypercortisolism, or Cushing's syndrome. While the Company touted the expected success of FDA approval, it failed to disclose that the FDA had in fact expressed concerns to Corcept about the adequacy of the Company's clinical development program assessing relacorilant's effectiveness and that relacorilant's New Drug Application faced a material risk of rejection.

If you currently own CORT and purchased prior to October 31, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301825

Source: Kuehn Law, PLLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Corcept Therapeutics Incorporated failed to disclose adverse facts concerning potential FDA approval of one of the Company’s lead new product candidates, relacorilant, a medication being developed for multiple indications, including the treatment of hypercortisolism, or Cushing’s syndrome. While the Company touted the expected success of FDA approval, it failed to disclose that the FDA had in fact expressed concerns to Corcept about the adequacy of the Company's clinical development program assessing relacorilant’s effectiveness and that relacorilant's New Drug Application faced a material risk of rejection.

If you currently own CORT and purchased prior to October 31, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814.  Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™  

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814

, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

If you currently own shares of Manhattan Associates stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=35966 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected].

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

$1.4 billion-asset Louisiana bank plans to strengthen digital experience and operational resilience

, /PRNewswire/ -- Jack Henry® (Nasdaq: JKHY) announced today that First American Bank and Trust has selected Jack Henry's technology solutions to strengthen operations, enhance its digital banking experience, and support continued growth across Southeast Louisiana.

Founded in 1910 in Vacherie, Louisiana, First American Bank and Trust is a privately owned community bank with 25 locations. The bank serves retail and small business customers across Southeast Louisiana, with a strong foundation in residential lending and a growing focus on expanding its small business portfolio. The institution is deeply rooted in its local communities and known for its culture-driven approach to customer service.

To better meet evolving customer expectations and remain competitive with larger regional and national institutions, First American Bank and Trust selected Jack Henry's modern core processing platform. The bank will move from an in-house environment to a hosted model, improving efficiency while enhancing disaster recovery and resiliency – critical in a region frequently impacted by hurricanes.

The Banno Digital Platform™ will improve the bank's digital experience, giving customers greater visibility into their financial lives with tools such as credit scoring and enhanced financial insights. These capabilities are embedded into the platform to provide customers with better control of their finances. And, Tap2Local™ will support the bank's goal of growing its small business portfolio by providing it with a simple, integrated solution for accepting payments and streamlining accounting. The bank will further differentiate through Jack Henry's open ecosystem, which offers open integrations to more than 1,000 third-party fintechs.

"We were looking for a technology provider that can help us move forward while staying true to who we are as a community bank," said Ronnie Falgoust, President and CEO of First American Bank and Trust. "Jack Henry stood out for its strong reputation for customer support, ongoing investment in innovation, and open approach to technology. This will help us deliver better tools and experiences for our customers while supporting our plans to grow organically, particularly on the small business side."

Jack Henry's strategy of delivering modern service components in the public cloud was also a key factor for First American Bank and Trust. "You can see the pace of innovation in how their platform continues to evolve, making them stand out on the market," Falgoust added. "This ongoing development, combined with what we heard from peers, gave us confidence that we're making the right decision."

"First American Bank and Trust has built a strong legacy by continuing to evolve alongside its customers," said Jonathan Baltzell, President of Bank Solutions at Jack Henry. "With the right technology in place, the bank is well positioned to scale, innovate, compete, and deliver the experiences that make it the center of their accountholders' financial journeys."

About Jack Henry & Associates, Inc.® 

Jack Henry® (Nasdaq: JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions and the people and businesses they serve. We are an S&P 500 company that prioritizes openness, collaboration, and user centricity – offering banks and credit unions a vibrant ecosystem of internally developed modern capabilities as well as the ability to integrate with leading fintechs. For 50 years, Jack Henry has provided technology solutions to enable clients to innovate faster, strategically differentiate, and successfully compete while serving the evolving needs of their accountholders. We empower approximately 7,400 clients with people-inspired innovation, personal service, and insight-driven solutions that help reduce the barriers to financial health. Additional information is available at www.jackhenry.com. 

SOURCE Jack Henry & Associates, Inc.

Investors with an interest in Transportation - Truck stocks have likely encountered both Knight-Swift Transportation Holdings (KNX) and Saia (SAIA). But which of these two stocks presents investors with the better value opportunity right now?

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: Rosen Law Firm is investigating potential civil securities claims.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Rosen Law Firm Encourages GoDaddy Inc. Investors to Inquire About Securities Class Action Investigation - GDDY PR Newswire

NEW YORK, June 18, 2026

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.

So What: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

What is this about: Rosen Law Firm is investigating potential civil securities claims.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-godaddy-inc-investors-to-inquire-about-securities-class-action-investigation--gddy-302803862.html

SOURCE THE ROSEN LAW FIRM, P. A.

Almost every business owner with a website has heard of GoDaddy (GDDY +1.12%). It's the world's largest website registrar and generates annual recurring revenue from numerous businesses that keep their domain names. Companies only stop paying this expense when they're out of business, which makes GoDaddy's revenue predictable.

However, there is meaningful growth hidden behind the overall results, and a 35% year-to-date dip has turned the company into an underrated value stock.

Image source: Getty Images.

GoDaddy doesn't just make money with domains Domain registration is still a large part of GoDaddy's business. It brought in $768.7 million in the first quarter of 2026, making up 60.7% of total revenue. It was up by only 2.8% year over year, which partially explains why the stock trades at an 8.5 forward P/E ratio.

Today's Change

(

1.12

%) $

0.85

Current Price

$

76.96

However, there is a true growth engine hidden beneath the domains. GoDaddy has a segment called applications and commerce that makes up the remaining 39.3% of revenue. Some people use GoDaddy to create websites, store data, promote e-commerce product listings seamlessly, and design branding assets.

This part of the business grew by 11.6% year over year in Q1. It will gradually make up a higher percentage of total revenue, and it gives people who buy a GoDaddy domain more reasons to stick with the GoDaddy ecosystem.

GoDaddy is using AI to enhance its offerings The "applications and commerce" segment is already delivering respectable growth, but GoDaddy's AI investments can accelerate future gains for that part of the business. The company recently released the Airo AI Builder, which lets business owners design websites, e-commerce stores, and apps using AI prompts.

This tool saves business owners a lot of time, and it's already translating into revenue growth. GoDaddy told investors in its Q1 press release that the Airo AI Builder had "strong early adoption" and achieved a multimillion-dollar annualized bookings run rate within weeks of its beta launch.

GoDaddy's total revenue was $1.3 billion in Q1, which was a 6% year-over-year increase. This figure indicates that the Airo AI Builder still makes up a very small slice of total revenue. However, if momentum continues to build, it can start to influence overall sales.

The success also suggests that GoDaddy will continue to introduce new AI-enabled products and services. That can open up more revenue streams and ensure that the "applications and commerce" segment continues to exhibit double-digit year-over-year growth rates.

If the hottest part of the business continues to remain hot, the 8.5 forward P/E ratio looks like an absolute bargain. While some tech stocks continue to soar, leaving them vulnerable in the event of rising interest rates or broader corrections, GoDaddy offers steady growth and a greater margin of safety than most picks.

, /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report.

Quest Diagnostics 2025 Corporate Responsibility Report Reach and Impact Statistics The theme of the report, At the Center of Healthcare, reflects Quest's connective role in healthcare as a provider of laboratory insights that empower more informed, proactive and personal care. The 2025 report details Quest's accomplishments over the last year and progress toward goals set in 2021 across the company's four strategic pillars of corporate responsibility: health access, employee and community engagement, governance and ethics, and environmental sustainability.

"Our care for the many communities we serve and live in shines through the actions we've taken to broaden healthcare access and improve our employee experience and environmental impact," said Jim Davis, Quest Diagnostics Chairman, CEO and President. "Over the past year, we made our services accessible and affordable for more patients and consumers, invested in our people, and strengthened our policies and systems in areas, such as medical quality and AI, that reflect Quest's deep focus on responsible business practice. These achievements demonstrate the passion and commitment of our nearly 57,000 employees and many collaborators across healthcare to working together to create a healthier world, one life at a time."

Report highlights:

Health access

Provided over one million discounted or donated testing requisitions to support lab testing access at a cost of more than $21 million to Quest. Through the Quest Diagnostics Foundation, invested in nonprofits and other organizations committed to improving access to healthcare, nutrition, and vital support services for underserved populations in Baltimore, Maryland, Paterson, New Jersey, and Chicago, Illinois. Employee and community engagement

Improved overall workforce retention by 2.1 percentage points compared to 2024 and achieved an Employee Engagement score 3 points above a healthcare industry benchmark. Welcomed over 2,500 employees to eleven employee business networks, surpassing 11,000 members. Governance and ethics

Added the new role of senior vice president and chief quality and regulatory affairs officer and strengthened global organizational quality and regulatory processes.   Enhanced our AI and cybersecurity governance to promote responsible use of AI and bolster systems to address emerging security threats. Environmental sustainability

Achieved International Organization for Standardization (ISO) 14001:2015 certification for the environmental management systems at our laboratories in Lewisville, Texas and Marlborough, Massachusetts, reaching our goal to certify five labs by the end of 2025. Supported access to testing for individuals exposed to environmental health hazards, including firefighters affected by the 2025 Palisades fire in Los Angeles County and citizens in a Texas-designated cancer cluster. To read the full report, click on 2025 Corporate Responsibility Report.

About Quest Diagnostics 

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com. 

SOURCE Quest Diagnostics

Published in Nature Communications, the new study finds that nearly 70% of a common bacterial strain that causes urinary tract infections, pneumonia and wound infections was non-susceptible to the three most used oral antibiotics

, /PRNewswire/ -- A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now.

Klebsiella pneumoniae is a growing drug-resistance problem, according to a groundbreaking new study in the peer-reviewed Nature Communications by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI), part of Hackensack Meridian Health (HMH), and Quest Diagnostics (NYSE: DGX), one of the nation's leading providers of diagnostic information services.

More than 2,000 samples across 42 states were screened through the collaboration, as outlined in the paper entitled "Nationwide spread of multidrug resistant Klebsiella pneumoniae across U.S. communities." A total of 267 multidrug resistant sequence types were identified, the data finds.

"For a long time, highly resistant superbugs were primarily considered a problem for hospitals, but this study reveals a dangerous shift. These bacteria are spreading, and causing common infections that are resistant to the recommended antibiotics used to treat them," said co-author Meghan W. Starolis, MS, Ph.D., senior science director, Infectious Disease, Quest Diagnostics. "This research provides critical updates for public health, and, more importantly, it provides the genetic blueprint needed to start developing vaccines or other treatments for vulnerable patients."

Klebsiella pneumoniae is an overlooked threat. It not only causes urinary tract infections, pneumonia and wound infections, but also kills about 600,000 individuals annually worldwide, according to the World Health Organization. In the United States, it's the most common cause of hospital-acquired pneumonia. Worldwide, it's the second-leading cause of UTIs – and has shown itself to be especially prevalent in women of advanced age.

"Our work shows that there is a rapidly-evolving, plasmid-driven epidemic of community-associated multidrug resistant Klebsiella pneumoniae across the United States," said co-author Barry Kreiswirth, Ph.D., the veteran microbiologist at the CDI and professor of Medical Sciences at the Hackensack Meridian School of Medicine, who spearheaded the years-long project. "We need to continue surveillance of what these bacteria are doing, so we can detect, and ideally control, the emergence of the next high-risk clone."

Of the roughly 2,000 samples in the study, more than two-thirds were from female patients, and about three-quarters were from people older than 60. All told, 100 percent of the bacteria investigated were classified as multidrug resistant, and 69.5 percent were non-susceptible to the three most common oral antibiotics (fluoroquinolones, Bactrim and nitrofurantoin), "underscoring the urgent need for new oral treatment options." For patients who have these strains, the only option may be injectable antibiotics, said Kreiswirth.

The main culprit in this resistance spread is a gene known as CTX-M-15, which is easily swapped between different bacteria on plasmids (stray strands of DNA outside chromosomes). The gene has spread to hundreds of strains, bringing with it not only antibiotic-resistance traits but also tolerance for stress and metal exposure which has potentially enhanced its survival outside of human hosts, according to the findings.

The multidrug-resistant strains were previously identified mostly as a healthcare-associated pathogen. Beginning around 2007, however, studies started to identify an "expanding and under-recognized reservoir" of the culprit Extended-Spectrum Beta-Lactamase (ESBL) gene. The U.S. Centers for Disease Control and Prevention conducted a study finding a 53.3 percent increase in ESBL-producing bacteria between 2012 and 2017 – pointing toward community transmission.

The study by the CDI and Quest bridges that gap, the authors write. Geographical trends  showed regional and statewide spread, and multi-state dissemination, "indicating widespread, underrecognized community reservoirs," according to the analysis.

Quest and CDI worked together to make this research possible. Using its nationwide network of microbiology labs, Quest Diagnostics provided CDI with deidentified culture isolates that were determined to be resistant to antibiotics for further sequencing by CDI, providing the researchers with a diverse sample set for analyzing.

"This is establishing a baseline," concluded Kreiswirth. "We need to keep looking at this to better understand the extent of the problem. But this is definite confirmation that there is a problem – and it needs to be addressed."

The study's strengths include its large scale and unique focus on everyday community infections rather than hospital cases; however, its limitation is the lack of detailed patient medical histories, making it difficult to know exactly where or how the patients originally contracted the infections.

"We are very proud to collaborate with the Center for Discovery and Innovation on this research," said Yuri Fesko, M.D., senior vice president and chief medical officer, Quest Diagnostics. "Relationships between commercial clinical labs and research organizations like CDI are so important to improving and informing public health."

Quest and Hackensack Meridian have a long-standing collaboration through which Quest provides reference laboratory testing and manages HMH's inpatient hospital labs. The study is the largest yet by researchers with the two NJ-based organizations.

ABOUT HACKENSACK MERIDIAN HEALTH
Hackensack Meridian Health brings together leading–edge care, research, and medical education to deliver the best outcomes, and care shaped around the unique needs of every patient we serve. By connecting prevention, specialty care, and life-saving discoveries, we improve every aspect of healthcare – from routine visits to the most advanced treatments, close to home and across the globe.

Home to New Jersey's first and only top 20 hospital in the nation according to U.S. News & World Report 2025-26, we ensure people can count on exceptional care today and benefit from the cures of tomorrow. Our not-for-profit network of 18 hospitals, 500+ care locations, and over 40,000 team members extend the horizon of health for all. And because medicine is never finished, we Keep Getting Better for every patient, family, and community who counts on us. Learn more at HackensackMeridianHealth.org and to donate visit GiveHMH.org. 

About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com 

SOURCE Quest Diagnostics

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Quest Diagnostics (DGX - Free Report) Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. provides diagnostic information services to a broad range of customers within its primary customer channels of physicians, hospitals, patients, and consumers. The company provides services to Independent Delivery Networks (IDN) throughout the United States, through its Professional Lab Services (PLS) offerings, which allow them to build and execute their laboratory strategy, improve quality, reduce healthcare costs, and focus on core competencies. The company is a key provider of reference testing for approximately half of the hospitals in the United States.

DGX is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.

Momentum investors should take note of this Medical stock. DGX has a Momentum Style Score of B, and shares are up 0.6% over the past four weeks.

For fiscal 2026, 10 analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.11 to $10.72 per share. DGX boasts an average earnings surprise of +3.5%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, DGX should be on investors' short list.

Investors with an interest in Gaming stocks have likely encountered both Churchill Downs (CHDN - Free Report) and Take-Two Interactive (TTWO - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.

Churchill Downs has a Zacks Rank of #2 (Buy), while Take-Two Interactive has a Zacks Rank of #4 (Sell) right now. Investors should feel comfortable knowing that CHDN likely has seen a stronger improvement to its earnings outlook than TTWO has recently. However, value investors will care about much more than just this.

Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

CHDN currently has a forward P/E ratio of 12.28, while TTWO has a forward P/E of 34.27. We also note that CHDN has a PEG ratio of 0.59. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. TTWO currently has a PEG ratio of 3.43.

Another notable valuation metric for CHDN is its P/B ratio of 5.71. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, TTWO has a P/B of 12.13.

These metrics, and several others, help CHDN earn a Value grade of A, while TTWO has been given a Value grade of F.

CHDN sticks out from TTWO in both our Zacks Rank and Style Scores models, so value investors will likely feel that CHDN is the better option right now.

Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Acco Brands (ACCO) or SharkNinja, Inc. (SN). But which of these two stocks offers value investors a better bang for their buck right now?

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Banco Macro S.A. (BMA - Free Report) : This banking products and services company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.1% over the last 60 days.

Ternium S.A. (TX - Free Report) : This steel manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.1% over the last 60 days.

Delek US Holdings, Inc. (DK - Free Report) : This integrated downstream energy company has seen the Zacks Consensus Estimate for its current year earnings increasing 101.5% over the last 60 days.

Cognex Corporation (CGNX - Free Report) : This machine vision company has seen the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.

Littelfuse, Inc. (LFUS - Free Report) : This electronics manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

, /PRNewswire/ -- Alpha Metallurgical Resources, Inc. (NYSE: AMR), a leading U.S. supplier of metallurgical products for the steel industry, today announced that a key piece of equipment at Dominion Terminal Associates (DTA) in Newport News, Va. sustained significant damage as a result of high winds in Sunday evening's storm. The equipment, a stacker reclaimer machine, is one of two such devices at DTA used to move coal into and out of stockpiles at the terminal. The second stacker reclaimer machine, which was refurbished earlier this year, remains intact and operational.

At this time, DTA officials are working to understand the scope of the damage to the stacker reclaimer, which sustained wind gusts of more than 80 miles per hour during an evening storm on June 14. The machine is currently inoperable. As a result, Alpha is has sent force majeure letters to affected customers. With a 65% majority ownership interest in DTA, Alpha utilizes the terminal for most of its export shipments but maintains additional shipping capacity at neighboring terminals.

Terminal leaders are working to determine a timeline and plan of action for the damaged stacker reclaimer.

About Alpha Metallurgical Resources

Alpha Metallurgical Resources (NYSE: AMR) is a Tennessee-based mining company with operations across Virginia and West Virginia. With customers across the globe, high-quality reserves and significant port capacity, Alpha reliably supplies metallurgical products to the steel industry. For more information, visit www.AlphaMetResources.com.

Forward-Looking Statements

This news release includes forward-looking statements. These forward-looking statements are based on Alpha's expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Alpha's control. Forward-looking statements in this news release or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Alpha to predict these events or how they may affect Alpha. Except as required by law, Alpha has no duty to, and does not intend to, update or revise the forward-looking statements in this news release or elsewhere after the date this release is issued. In light of these risks and uncertainties, investors should keep in mind that results, events or developments discussed in any forward-looking statement made in this news release may not occur. See Alpha's filings with the U.S. Securities and Exchange Commission for more information.

INVESTOR & MEDIA CONTACT: EMILY O'QUINN
[email protected]
[email protected]
(423) 573-0369

SOURCE ALPHA METALLURGICAL RESOURCES, INC.

Key Takeaways OUTFRONT Media draws investor attention as digital and transit advertising trends improve in 2026.OUT's transit revenues rose 22.3% in Q1, with digital transit revenues up 25.6% to $44.7M.OUT expects about 125 digital billboard additions in 2026, as displays average 4-5x static revenue. OUTFRONT Media Inc. (OUT - Free Report) has drawn closer investor attention as digital and transit advertising trends improve in 2026.

The setup is not one-sided. A broad U.S. footprint, improving transit demand and digital conversions support growth, while advertising cyclicality and capital needs keep the outlook balanced.

OUTFRONT Media Has a Wide National Ad Footprint

OUTFRONT is one of the largest U.S. out-of-home advertising operators, with billboard and transit displays in approximately 120 markets, including the 25 largest markets. Its billboard assets are mainly located on heavily traveled highways and roadways, while its transit displays are operated through municipal contracts in large U.S. cities.

That mix gives brands national reach with local execution. It also diversifies OUT’s revenue base across advertiser categories, with entertainment, legal services/lawyers and retail representing 18%, 12% and 10%, respectively, of first-quarter 2026 Billboard and Transit segment revenues.

OUT Gains From Digital Billboard ExpansionDigital conversion remains one of OUT’s clearer growth levers. Total digital displays reached 31,565 as of March 31, 2026, including 1,932 digital billboard displays and 29,633 digital transit displays.

The company converted 14 new billboards to digital in the first quarter and expects to add about 125 for the full year. Digital billboard displays generate roughly four to five times more revenue per display on average than comparable static billboard displays, although they also carry higher costs.

OUTFRONT Media Sees Transit Demand ImproveTransit is a major part of the 2026 improvement story. First-quarter transit revenues rose 22.3% year over year to $95.0 million, while digital transit revenues increased 25.6% to $44.7 million.

Management expects second-quarter revenue growth to exceed 10%, supported by about 30% growth in transit and mid-single-digit growth in billboard. The launch of OUT’s advertising and experiential program at Los Angeles Union Station adds premium transit inventory, with the station’s World Cup 26 Fan Zone role adding potential brand appeal.

OUT Faces Cyclical Ad Demand and Higher SpendingAdvertising remains economically sensitive. OUT’s revenues and operating results are exposed to shifts in advertiser budgets, general economic conditions and competition from online, mobile, social media, television, radio, print and other out-of-home formats.

Capital spending is another constraint. Total capital expenditures rose 40.1% year over year to $24.1 million in the first quarter, and management still expects approximately $90 million of capital expenditures in 2026, including $30-$35 million of maintenance capital expenditures.

How OUT Signals Fit the Current SetupThe bottom line is that OUT’s operating signals look constructive, but not without offsets. Digital adoption, transit momentum and portfolio breadth support the growth case, while cyclical ad demand, competition and capital intensity argue for patience.

OUT currently carries a Zacks Rank #3 (Hold), with a Value Score of B, Growth Score of B, Momentum Score of B and VGM Score of A. That combination points to balanced style appeal, but the Hold rank keeps the near-term view measured rather than outright bullish. 

In the past three months, shares of this company have gained 15.1% compared with the industry's growth of 7.1%. 

Image Source: Zacks Investment Research

Within the broader REIT space, American Tower Corporation (AMT - Free Report) and Cousins Properties Incorporated (CUZ - Free Report) offer useful context for investors comparing real estate-backed income and growth profiles. AMT currently carries a Zacks Rank #2 (Buy), while CUZ also carries a Zacks Rank #2, giving investors other REIT names to monitor alongside OUT’s improving but still mixed setup. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.

FN Media Group Presents Oilprice.com Market Commentary

, /PRNewswire/ -- If you've been following in the AI boom, you probably are aware of the same names everyone else is. NVIDIA for the chips. Microsoft, Google and Amazon for the cloud. Maybe Meta for the consumer side. Maybe Palantir or one of the AI software names. Possibly TSMC for exposure to the manufacturing layer. And that awareness has worked well for many. NVIDIA alone has minted more wealth in two years than most companies create in a century. The hyperscalers have all hit fresh highs. AI software stocks that were speculative bets in 2022 now trade at premium multiples.  Companies mentioned in today's commentary includes:  Bitzero Holdings Inc. (AIBZ), Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOGL), ASML Holding N.V. (NASDAQ: ASML), Arm Holdings plc (NASDAQ: ARM), Super Micro Computer, Inc. (NASDAQ: SMCI).

But everyone interested in this industry should be asking the same question right now. With most of these names sitting at or near all-time highs, where does the next leg of returns come from? The answer won't come from the obvious places. The chip makers, the cloud providers and the software creators have already gotten a ton of attention. To find the kind of returns that actually move the needle in 2026, you have to look one layer beneath the names everyone is talking about. You have to look at what makes all of it possible.

One company well positioned for what's coming is one most people have never heard of. It's called Bitzero Holdings, Inc. (AIBZ), and to understand why it matters, you need to understand the bottleneck nobody is talking about yet. 

The Question Wall Street Forgot to Ask
Every company in the AI economy depends on one thing. NVIDIA's chips are useless without it. Microsoft's data centers are concrete shells without it. Google's models can't train without it. The entire industry runs on one input that almost nobody talks about. Electricity. And there isn't enough of it.

A single ChatGPT query consumes roughly 10 times the energy of a Google search. Training the next generation of large language models requires the equivalent power draw of small cities. Industry forecasts now put AI data center capital expenditure at roughly $5.2 trillion between now and 2030. Goldman Sachs Research projects global data center power demand will surge up to 165% by 2030 compared to 2023 levels.

The Hyperscalers Already Know
If you want confirmation that power is the real constraint, look at what the smart money is doing. Microsoft signed a 20-year deal to restart the Three Mile Island nuclear plant, a facility that has been offline since 2019, specifically to feed its AI ambitions. Amazon paid $650 million for a data center campus directly co-located with the Susquehanna nuclear station in Pennsylvania. Google announced agreements with Kairos Power for small modular reactors.

These are not the moves of companies that think power will sort itself out. They are willing to commit billions and wait years to lock in scarce, secured, low-carbon electricity because they know that power is the binding constraint on their entire AI strategy. 

The Standout Play in a Closed Market
Bitzero Holdings, Inc. (AIBZ) is one of the very few companies that locked in Nordic power capacity ahead of the surge. The story of how it did so explains why this stock is one of the rare chances to own real AI infrastructure before Wall Street catches on.

Bitzero controls more than 1 gigawatt of secured, low-cost power capacity across four strategic sites in Norway, Finland and the United States. That capacity is permitted, contracted and in many cases already operational. The largest single block of that capacity, the 110 megawatts at the company's Norwegian flagship, is now under a binding 15-year lease worth approximately $2.6 billion. More on that in a moment. 

The crown jewel is the company's Norwegian flagship at Namsskogan, where Bitzero operates as a licensed grid operator at the 132 KV level. That's an unusual position. It is also an extraordinarily valuable one.

Most data center operators connect at 22 KV through a utility, paying middleman fees and waiting on utility timelines. Bitzero connects directly to the high-voltage grid and works directly with hydroelectric power plants, bypassing the middlemen and multi-year utility wait that hold most projects back. 

The financial impact is dramatic. Bitzero's all-in power cost at its Norway facility, including grid fees, taxes and every other charge, currently sits at 3-4 cents per kilowatt-hour. The US average is closer to 12 cents. American data center operators competing for AI workloads are paying three to four times what Bitzero pays for the same electron.

The Deals That Changed What This Company Is
Three months ago, Bitzero looked like a small Bitcoin miner with an unusually good power position. Today it looks like something different entirely. The transformation comes down to four announcements, all landing inside a single rolling window. 

The biggest by far is OneQode. On May 5, 2026, Bitzero signed a binding letter with OneQode Networks Pte. Ltd. for a 15-year lease of the full 110 megawatts at its Namsskogan, Norway site. Total contracted revenue runs approximately $2.6 billion, with implied annual revenue of $178 million at full capacity and a net operating margin of 85%. The tenant is deploying GPU clusters for enterprise AI, large language model training and sovereign AI workloads. Commissioning is targeted for the first half of 2027, with the lease then running through 2042 at minimum. The buildout to convert the site to HPC-grade specifications runs roughly $1.1 billion, with debt financing in late-stage negotiation. The deal is subject to definitive documentation, which management has indicated could close within the next 60 to 90 days.

On a per-megawatt basis, the OneQode deal lines up with the comparable HPC leases driving the multi-billion dollar valuations of larger peers. TeraWulf sits on $12.8 billion in contracted HPC revenue. Hut 8 signed a $7 billion, 15-year lease with Fluidstack for 245 megawatts. Core Scientific signed a $10.2 billion deal with CoreWeave across roughly 500 megawatts. Each of those announcements rerated the company's stock substantially.

The other three announcements build on the OneQode foundation. In January 2026, Bitzero announced that it had retained CBRE as the strategic broker for its 200-megawatt Finland site. CBRE is not a small player. The firm manages roughly $6 billion in annual data center transaction value and has direct, active relationships with every hyperscaler on earth. In the same month, Bitzero announced a partnership with Hydra Host, a top-10 NVIDIA Cloud Partner backed by Founders Fund.  Hydra Host operates GPU clusters across more than 50 locations worldwide and brings Bitzero's compute capacity to a global enterprise customer base through its Brokkr platform. A few days later, Bitzero acquired its first eight NVIDIA Blackwell B300 servers (64 GPUs total) for deployment at the Norway site, marking the company's first direct entry into AI compute revenue.

Already Profitable…And Just Getting Started
The part that separates Bitzero from most early-stage infrastructure plays is simple. The company is not burning capital while it waits for AI deals to close. It is generating revenue today. Bitzero mines Bitcoin at its Norway site at a blended power cost of approximately $0.03 to $0.035 per kWh. The all-in cost to mine one Bitcoin sits around $50,000, roughly half the industry average of $100,000. The company's hashrate has grown steadily from 0.4 EH/s in early 2024 to 1.08 EH/s by January 2025 to roughly 2.80 EH/s today, a 7x increase in two years. At current network conditions that's around 1.1 Bitcoin per day in production.

That revenue funds operations and demonstrates infrastructure reliability under sustained, real-world high-load conditions. AI customers want to see exactly that before signing multi-year hosting agreements.The 110 megawatts at Namsskogan are now committed to OneQode under the 15-year lease, with HPC commissioning targeted for the first half of 2027. The growth runway extends well beyond that initial block. Bitzero has a clear path to approximately 325 megawatts at the same site by late 2027, with the largest infrastructure components, including a Siemens GIS breaker with 200 megawatt capacity, already paid for and installed. Whatever capacity does not flow to OneQode in later phases becomes available for either additional HPC tenants or expanded mining.

Other companies to keep an eye on: 

Amazon.com, Inc. (NASDAQ: AMZN) may be making the most aggressive single bet on AI infrastructure of any company on this list. The company announced $200 billion in capital expenditures for 2026, the bulk of it aimed at AWS data centers — up from $96.5 billion spent in 2025 and $83 billion in 2024. CEO Andy Jassy told investors that all new AWS capacity sells out immediately, with demand limited by supply factors like energy and hardware, not customer appetite.

Q1 FY2026 results reinforced that narrative. AWS grew 28%, its fastest clip in 15 quarters, on a very large base. Amazon's custom chip business — Trainium — crossed a $20 billion annualized revenue run rate, growing triple digits year over year.

Alphabet Inc. (NASDAQ: GOOGL) is approaching the AI data center race from a position of unusual strategic depth. Unlike its hyperscaler peers, Google designs and manufactures its own AI chips — Tensor Processing Units — giving it a degree of supply chain independence that Microsoft and Amazon lack. That vertical integration is showing up in the numbers: the company reduced Gemini serving unit costs by 78% over 2025 through model optimizations and efficiency improvements.

The spending commitment is massive either way. Alphabet guided 2026 capital expenditures to between $180 billion and $190 billion — more than double its 2025 figure — with CFO Anat Ashkenazi flagging that 2027 capex is expected to "significantly increase" from there.

ASML Holding N.V. (NASDAQ: ASML) is the only company in the world that makes extreme ultraviolet lithography machines — the equipment required to print every leading-edge AI chip. There is no alternative supplier. Q1 2026 net sales reached €8.8 billion, up 13% year over year, at a 53% gross margin that is exceptional for capital equipment manufacturing. The company raised its full-year 2026 revenue guidance to €36 to €40 billion from a prior range of €34 to €39 billion, citing AI-driven demand that CEO Christophe Fouquet said is pushing chip demand well beyond current supply.

The China headwind is real and worth flagging. System sales to China fell to 19% of total in Q1 2026, down from 36% in Q4 2025, as export controls progressively restrict what ASML can sell there. The pre-buying cycle for lower-end DUV machines has run its course, and EUV has never been permitted for Chinese customers. A

Arm Holdings plc (NASDAQ: ARM) doesn't make chips. It designs the instruction set architectures that most of the world's chips are built on — and then collects royalties every time one of those chips ships. Every AWS Graviton processor, every Apple M-series chip, every NVIDIA Vera CPU runs on Arm architecture. Q4 FY2026 revenue hit $1.49 billion, up 20% year over year, with data center royalties more than doubling year over year for the second consecutive quarter.

The data center story for Arm is that its architecture is now winning the hyperscaler CPU market at scale. Arm-based CPUs hold approximately 50% market share among the top hyperscalers — AWS Graviton and Trainium, Google Axion and TPUs, Microsoft Cobalt, NVIDIA's Vera CPU — all run on Arm.

Super Micro Computer, Inc. (NASDAQ: SMCI) designs and manufactures the high-performance servers and rack-scale systems that sit inside AI data centers, competing directly with Dell in the GPU server market. The company pioneered the direct liquid cooling rack solutions that are now industry standard for high-density AI workloads, and it counts NVIDIA as a core supply chain partner.

The company has had a turbulent period from a governance standpoint. Super Micro faced an accounting investigation and delayed several financial filings in 2024 and 2025, which rattled the industry even as the underlying server business continued to grow.

By. Tom Kool

Oilprice Intelligence brings you the inside view on where the next gains will come from, breaking down the market's biggest growth driver with analysis from veteran oilmen and experts. Click here to get this crucial intel for free

IMPORTANT NOTICE AND DISCLAIMER
Neither the author nor the publisher, Oilprice.com, was paid to publish this communication concerning Bitzero Holdings, Inc. (AIBZ). The owner of Oilprice.com owns shares and/or stock options of the featured company and therefore has an incentive to see the featured company's stock perform well. The owner of Oilprice.com may buy or sell shares of the featured company at any time including at or near the time you receive this communication. This share ownership should be viewed as a major conflict with our ability to be unbiased. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://oilprice.com/terms-and-conditions If you do not agree to the Terms of Use http://oilprice.com/terms-and-conditions, please contact Oilprice.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY. Oilprice.com is the Publisher's trademark. All other trademarks used in this communication are the property of their respective trademark holders.  The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.

This press release was distributed on behalf of Bitzero Holdings Inc.

DISCLAIMER:  OilPrice.com is Source of all content listed above.  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with OilPrice.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by OilPrice.com are solely those of OilPrice.com and are not shared by and do not reflect in any manner the views or opinions of FNM.  FNM is not liable for any investment decisions by its readers or subscribers.  FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty one hundred dollars by Bitzero Holdings Inc. to distribute this release on behalf of the company.  #tickertagpressreleases #pressrelease #stockalerts

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:
Media Contact e-mail:  [email protected]
U.S. Phone: +1(561)486-1799
OilPrice.com
+44 203 239 4080
[email protected]

SOURCE: Oilprice.com

NEW YORK--(BUSINESS WIRE)--Urban Edge Properties (NYSE: UE) announced today that it will release its second quarter earnings prior to the market open on Friday, August 7, 2026. The Company will host an earnings conference call and audio webcast on August 7, 2026 at 8:30 AM ET.

All interested parties can access the earnings call by dialing 1-877-407-9716 (Toll Free) or 1-201-493-6779 (Toll/International) using conference ID 13760790 or by using the following link for instant telephone access to the event: Call Me. The call will also be webcast and available in listen-only mode at this link: UE Second Quarter 2026 Earnings Conference Call, or on the investors page of our website: www.uedge.com.

If you are unable to participate in the live call, a replay will be available at the webcast link above, or on the investors page of our website for one year following the conclusion of the call. A telephonic replay of the call will also be available starting Friday, August 7, 2026 at 11:30 AM ET through Friday, August 21, 2026 at 11:59 PM ET by dialing 1-844-512-2921 (Toll Free) or 1-412-317-6671 (Toll/International) using conference ID 13760790.

ABOUT URBAN EDGE PROPERTIES

Urban Edge Properties is a NYSE listed real estate investment trust focused on owning, managing, acquiring, developing, and redeveloping retail real estate in urban communities, primarily in the Washington, D.C. to Boston corridor. Urban Edge owns 74 properties totaling 17.3 million square feet of gross leasable area.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: HealthEquity (HQY - Free Report) Draper, UT-headquartered HealthEquity provides integrated solutions for healthcare account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States.

HQY is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. HQY has a Growth Style Score of A, forecasting year-over-year earnings growth of 17.8% for the current fiscal year.

Six analysts revised their earnings estimate higher in the last 60 days for fiscal 2027, while the Zacks Consensus Estimate has increased $0.10 to $4.71 per share. HQY also boasts an average earnings surprise of +12%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, HQY should be on investors' short list.

Surgery Partners (SGRY - Free Report) closed the last trading session at $14.23, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.95 indicates a 26.1% upside potential.

The mean estimate comprises 11 short-term price targets with a standard deviation of $2.9. While the lowest estimate of $14.00 indicates a 1.6% decline from the current price level, the most optimistic analyst expects the stock to surge 68.7% to reach $24.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.

However, an impressive consensus price target is not the only factor that indicates a potential upside in SGRY. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why SGRY Could Witness a Solid UpsideAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current year, one estimate has moved higher over the last 30 days compared to no negative revision. As a result, the Zacks Consensus Estimate has increased 44.1%.

Moreover, SGRY currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much SGRY could gain, the direction of price movement it implies does appear to be a good guide.

-

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly).

"The combination of Charles River’s decades-long expertise in nonclinical testing with TuneLab’s innovative AI/ML models will support the accelerated development of innovative therapeutics."

Share TuneLab was created to accelerate biotech innovation by enabling participating companies to access AI/ML drug discovery models trained on decades of Lilly's proprietary research data, in exchange for data contributions that improve model performance through federated learning. Participating companies may use the TuneLab prediction models to more rapidly down-select candidate molecules. Through this collaboration, Charles River will provide nonclinical testing services to TuneLab companies.

“The combination of Charles River’s decades-long expertise in nonclinical testing with TuneLab’s innovative AI/ML models will support the accelerated development of innovative therapeutics,” said Dr. Namandjé N. Bumpus, Chief Science and Innovation Officer, Charles River. “TuneLab’s collaborative AI platform democratizes access to pharma-grade tools, relieving a substantial resource burden for biotechs. By layering in Charles River’s industry-leading hands-on research experience, TuneLab participants have access to additional validation that supports discovery decision-making.”

Standardizing protocols with nonclinical testing across the TuneLab ecosystem should enable the AI/ML models to learn more efficiently from the ongoing contributions, improving the models further and increasing the efficiency of the TuneLab platform.

Lilly TuneLab is part of Lilly Catalyze360, alongside Lilly Ventures, Lilly Gateway Labs, and Lilly ExploR&D, which together support biotech innovation by providing access to strategic capital, lab space and technology, and research and development capabilities.

Charles River remains committed to advancing the validation and acceptance of new approach methodologies (NAMs), including through its Alternative Methods Advancement Project™ (AMAP™) initiative. Together with clients, regulators, and industry, NAMs provide a foundation for a future where more patients gain access to life-saving treatments—safely, swiftly, and with reduced reliance on animal use in research where scientifically appropriate.

About the Alternative Methods Advancement Project (AMAP)

The Alternative Methods Advancement Project (AMAP) is a Charles River-led initiative dedicated to developing New Approach Methodologies (NAMs) and exploring innovative scientific and technological solutions aimed at reducing reliance on traditional animal testing. As we enter the next frontier of drug development, AMAP enables strategic, purpose-driven investment to shape a future in which more patients can access the treatments and medicines they need safely, swiftly, and successfully. AMAP is supported by our global, cross-functional Scientific Advisory Board led by Dr. Namandjé N. Bumpus.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

More News From Charles River Laboratories International, Inc.

Back to Newsroom